CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics CEO Frank Reynolds met with Massachusetts Governor Deval Patrick at the Massachusetts State House today in an advisory capacity regarding the national health care reform and its effect on the medical device sector in Massachusetts. Reynolds, along with the leaders of several other companies in the medical device industry such as Boston Scientific and Zoll, engaged in an open discussion with Governor Patrick and shared their opinions on the impact of the health care reform on the industry. Among topics discussed were the additional excise tax on medical device manufacturers that will be effective in 2013 and coverage for clinical trials.
